The global wireless implants market is expected to grow from USD 9.31 billion in 2025 to USD 39.52 billion by 2034, at a CAGR of 17.47%. The market is driven by the increasing prevalence of chronic health conditions, technological innovations, and the miniaturization of devices. North America holds the largest market share, while Asia-Pacific is anticipated to experience the fastest growth.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Wireless Implants Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Wireless Implants Market Revenue and Volume, by Application
8.1.1. Orthopedic Implants
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Cardiovascular Implants
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Neurological Implants
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Other implants
8.1.4.1. Market Revenue and Volume Forecast
9.1. Wireless Implants Market Revenue and Volume, by End-User
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Clinics
9.1.3.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Application
10.1.2. Market Revenue and Volume Forecast, by End-User
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Application
10.1.3.2. Market Revenue and Volume Forecast, by End-User
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Application
10.1.4.2. Market Revenue and Volume Forecast, by End-User
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Application
10.2.2. Market Revenue and Volume Forecast, by End-User
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Application
10.2.3.2. Market Revenue and Volume Forecast, by End-User
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Application
10.2.4.2. Market Revenue and Volume Forecast, by End-User
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Application
10.2.5.2. Market Revenue and Volume Forecast, by End-User
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Application
10.2.6.2. Market Revenue and Volume Forecast, by End-User
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Application
10.3.2. Market Revenue and Volume Forecast, by End-User
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Application
10.3.3.2. Market Revenue and Volume Forecast, by End-User
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Application
10.3.4.2. Market Revenue and Volume Forecast, by End-User
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Application
10.3.5.2. Market Revenue and Volume Forecast, by End-User
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Application
10.3.6.2. Market Revenue and Volume Forecast, by End-User
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Application
10.4.2. Market Revenue and Volume Forecast, by End-User
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Application
10.4.3.2. Market Revenue and Volume Forecast, by End-User
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Application
10.4.4.2. Market Revenue and Volume Forecast, by End-User
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Application
10.4.5.2. Market Revenue and Volume Forecast, by End-User
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Application
10.4.6.2. Market Revenue and Volume Forecast, by End-User
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Application
10.5.2. Market Revenue and Volume Forecast, by End-User
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Application
10.5.3.2. Market Revenue and Volume Forecast, by End-User
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Application
10.5.4.2. Market Revenue and Volume Forecast, by End-User
11.1. Medtronic
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbott Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Boston Scientific Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Cochlear Limited
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Zimmer Biomet Holdings, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. St. Jude Medical (now part of Abbott)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Dexcom, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Siemens Healthineers
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. LivaNova PLC
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. NXP Semiconductors
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description